Cargando…

Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology

BACKGROUND: The aim of the present study was to determine the maternal pre-pregnancy body mass index (BMI), first-trimester fasting blood sugar (FBS), and the combination of (BMI+FBS) cut-points for at-risk pregnant women conceived by assisted reproductive technology (ART) to better predict the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouhkan, Azam, Khamseh, Mohammad E., Moini, Ashraf, Pirjani, Reihaneh, Arabipoor, Arezoo, Zolfaghari, Zahra, Hosseini, Roya, Baradaran, Hamid Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334016/
https://www.ncbi.nlm.nih.gov/pubmed/30644242
http://dx.doi.org/10.22074/ijfs.2019.5505
_version_ 1783387657918742528
author Kouhkan, Azam
Khamseh, Mohammad E.
Moini, Ashraf
Pirjani, Reihaneh
Arabipoor, Arezoo
Zolfaghari, Zahra
Hosseini, Roya
Baradaran, Hamid Reza
author_facet Kouhkan, Azam
Khamseh, Mohammad E.
Moini, Ashraf
Pirjani, Reihaneh
Arabipoor, Arezoo
Zolfaghari, Zahra
Hosseini, Roya
Baradaran, Hamid Reza
author_sort Kouhkan, Azam
collection PubMed
description BACKGROUND: The aim of the present study was to determine the maternal pre-pregnancy body mass index (BMI), first-trimester fasting blood sugar (FBS), and the combination of (BMI+FBS) cut-points for at-risk pregnant women conceived by assisted reproductive technology (ART) to better predict the risk of developing gestational diabetes mel- litus (GDM) in infertile women. MATERIALS AND METHODS: In this nested case-control study, 270 singleton pregnant women consisted of 135 (GDM) and 135 (non-GDM) who conceived using ART were assessed. The diagnosis of GDM was confirmed by a one-step glucose tolerance test (O-GTT) using 75 g oral glucose. BMI was classified base on World Health Organization (WHO) criteria. The relationship between BMI, FBS, and BMI+FBS with the risk of GDM development was deter- mined by logistic regression and adjusted for confounding factors. Receiver operating characteristic (ROC) curve analysis was performed to assess the value of BMI, FBS, and BMI+FBS for the prediction of GDM. RESULTS: The GDM group had significantly higher age, BMI, family history of diabetes, and history of polycystic ovary syn- drome in comparison with the non-GDM group (P<0.05). Overweight and obese women had 3.27, and 5.14 folds increase in the odds of developing GDM, respectively. There was a 17% increase in the risk of developing GDM with each 1 mg/dl increase in fasting glucose level. The cut points for FBS 84.5 mg/dl (72.9% sensitivity, 74.4% specificity), BMI 25.4 kg/m(2) (68.9% sensitivity, 62.8% specificity), and BMI+FBS 111.2 (70.7% sensitivity, 80.6% specificity) was determined. CONCLUSION: The early screening and high-quality prenatal care should be recommended upon the co-occurrence of high FBS (≥84.5 mg/dl) in the first-trimester of the pregnancy and the BMI (≥25.4 kg/m(2)) in pre-pregnancy period in women undergone ART. The combination of BMI and FBS is considered a better prediction value.
format Online
Article
Text
id pubmed-6334016
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Royan Institute
record_format MEDLINE/PubMed
spelling pubmed-63340162019-04-01 Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology Kouhkan, Azam Khamseh, Mohammad E. Moini, Ashraf Pirjani, Reihaneh Arabipoor, Arezoo Zolfaghari, Zahra Hosseini, Roya Baradaran, Hamid Reza Int J Fertil Steril Original Article BACKGROUND: The aim of the present study was to determine the maternal pre-pregnancy body mass index (BMI), first-trimester fasting blood sugar (FBS), and the combination of (BMI+FBS) cut-points for at-risk pregnant women conceived by assisted reproductive technology (ART) to better predict the risk of developing gestational diabetes mel- litus (GDM) in infertile women. MATERIALS AND METHODS: In this nested case-control study, 270 singleton pregnant women consisted of 135 (GDM) and 135 (non-GDM) who conceived using ART were assessed. The diagnosis of GDM was confirmed by a one-step glucose tolerance test (O-GTT) using 75 g oral glucose. BMI was classified base on World Health Organization (WHO) criteria. The relationship between BMI, FBS, and BMI+FBS with the risk of GDM development was deter- mined by logistic regression and adjusted for confounding factors. Receiver operating characteristic (ROC) curve analysis was performed to assess the value of BMI, FBS, and BMI+FBS for the prediction of GDM. RESULTS: The GDM group had significantly higher age, BMI, family history of diabetes, and history of polycystic ovary syn- drome in comparison with the non-GDM group (P<0.05). Overweight and obese women had 3.27, and 5.14 folds increase in the odds of developing GDM, respectively. There was a 17% increase in the risk of developing GDM with each 1 mg/dl increase in fasting glucose level. The cut points for FBS 84.5 mg/dl (72.9% sensitivity, 74.4% specificity), BMI 25.4 kg/m(2) (68.9% sensitivity, 62.8% specificity), and BMI+FBS 111.2 (70.7% sensitivity, 80.6% specificity) was determined. CONCLUSION: The early screening and high-quality prenatal care should be recommended upon the co-occurrence of high FBS (≥84.5 mg/dl) in the first-trimester of the pregnancy and the BMI (≥25.4 kg/m(2)) in pre-pregnancy period in women undergone ART. The combination of BMI and FBS is considered a better prediction value. Royan Institute 2019 2019-01-06 /pmc/articles/PMC6334016/ /pubmed/30644242 http://dx.doi.org/10.22074/ijfs.2019.5505 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kouhkan, Azam
Khamseh, Mohammad E.
Moini, Ashraf
Pirjani, Reihaneh
Arabipoor, Arezoo
Zolfaghari, Zahra
Hosseini, Roya
Baradaran, Hamid Reza
Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
title Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
title_full Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
title_fullStr Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
title_full_unstemmed Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
title_short Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology
title_sort diagnostic accuracy of body mass index and fasting glucose for the prediction of gestational diabetes mellitus after assisted reproductive technology
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334016/
https://www.ncbi.nlm.nih.gov/pubmed/30644242
http://dx.doi.org/10.22074/ijfs.2019.5505
work_keys_str_mv AT kouhkanazam diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT khamsehmohammade diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT moiniashraf diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT pirjanireihaneh diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT arabipoorarezoo diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT zolfagharizahra diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT hosseiniroya diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology
AT baradaranhamidreza diagnosticaccuracyofbodymassindexandfastingglucoseforthepredictionofgestationaldiabetesmellitusafterassistedreproductivetechnology